ampk glp-1 The mTORC1/AMPK pathway plays a role in the beneficial effects of semaglutide (GLP-1 receptor agonist) on the liver of obese mice Introducing the Ultimate Weight Management

Medicaid Services proposed to expand Medicare Part D and Medicaid to cover weight loss drugs

Learn about the new Medicare Bridge program, state Medicaid rules, and how to appeal a denial.

Lipedema is a connective tissue disorder resulting is painful fatty nodules while lymphedema is swelling due to lymphatic fluid.

A new Phase 2 trial at Johns Hopkins testing the GLP-1 drug pegsebrenatide in progressive MS may finally explain why adults on diabetes medications for a decade show measurably slower brain shrinkage

844.464.3476.

A Complete 2026 Review of Telehealth GLP-1 Programs, Compounded vs FDA-Approved Medications, Pricing, Eligibility, and What Women Should Know Before Starting